[Other] Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

juliojuju Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-10-25 17:14

Reward20points

Edited by juliojuju at 2026-10-22 17:14

Title: Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial

Link: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01554-4

Thanks

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report